KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

Foresite Capital Management IV, LLC's Holding History (CIK: 0001704132)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 9,671,643 Value ($000) $25,727 Avg Close — Range —
Q4 2023
Shares 9,671,643 Value ($000) $22,922 Avg Close — Range —
Q3 2023
Shares 9,671,643 Value ($000) $13,540 Avg Close — Range —
Q2 2023
Shares 9,671,643 Value ($000) $29,305 Avg Close — Range —
Q1 2023
Shares 9,671,643 Value ($000) $60,448 Avg Close — Range —
Q4 2022
Shares 9,671,643 Value ($000) $58,997 Avg Close — Range —
Q3 2022
Shares 9,671,643 Value ($000) $115,576 Avg Close — Range —
Q2 2022
Shares 9,671,643 Value ($000) $121,959 Avg Close — Range —
Q1 2022
Shares 9,671,643 Value ($000) $108,903 Avg Close — Range —
Q4 2021
Shares 9,671,643 Value ($000) $171,382 Avg Close — Range —
Q3 2021
Shares 9,671,643 Value ($000) $222,641 Avg Close — Range —
Q2 2021
Shares 9,671,643 Value ($000) $225,156 Avg Close — Range —
Q1 2021
Shares 9,671,643 Value ($000) $301,368 Avg Close — Range —
Q4 2020
Shares 9,671,643 Value ($000) $384,738 Avg Close — Range —